Ginna G. Laport

Clinical Focus

• Cancer > Bone Marrow Transplant
• Cancer > Hematology
• Blood and Marrow Transplantation
• Hematology
• Medical Oncology

Administrative Appointments

• ASBMT Board of Directors, American Society of Bone Marrow Transplantation (2007 - 2010)
• NMDP Donor Safety Committee, National Marrow Donor Program (2009 - 2011)
• ASH Communications Committee, American Society of Hematology (2007 - 2010)
• ASCO Clinical Practice Committee, American Society of Clinical Oncology (2008 - 2010)

Honors and Awards

• Division Teaching Award, Dept of Medicine (2003)

Professional Education

Graduate & Fellowship Program Affiliations

• Medicine

Web Site Links

• Personal Web site

Research Interests

haploidentical transplantation, adoptive immnotherapy, follicular lymphoma, supportive care

Clinical Trials

• Donor Stem Cell Transplant in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma After First Complete Remission Recruiting
• A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft versus Host Disease Recruiting
• Allogeneic HCT using Nonmyeloablative Host Conditioning with TLI & ATG vs SOC in AML Recruiting
• Allogeneic Transplantation From Related Haploidentical Donors in Older Patients with Indolent Hematologic Malignancies Recruiting
• Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Recruiting

Publications

• TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Kohrt HE, Turnbull BB, Heydari K, Shizuru JA, Laport GG, Miklos DB, Johnston LJ, Arai S, Weng WK, Hoppe RT, Lavori PW, Blume KG, Negrin RS, Strober S, Lowsky R. Blood. 2009; 114 (5): 1099-109
• Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure. Benjamin JE, Chen GL, Cao TM, Cao PD, Wong RM, Sheehan K, Shizuru JA, Johnston LJ, Negrin RS, Lowksy R, Laport GG. Bone Marrow Transplant. 2009
• Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. Laport GG, Alvarnas JC, Palmer JM, Snyder DS, Slovak ML, Cherry AM, Wong RM, Negrin RS, Blume KG, Forman SJ. Blood. 2008; 112 (3): 903-9
• Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. Laport GG, Sandmaier BM, Storer BE, Scott BL, Stuart MJ, Lange T, Maris MB, Agura ED, Chauncey TR, Wong RM, Forman SJ, Petersen FB, Wade JC, Epner E, Bruno B, Bethge WA, Curtin PT, Maloney DG, Blume KG, Storb RF. Biol Blood Marrow Transplant. 2008; 14 (2): 246-55
• Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review. Laport GG, Leuk Lymphoma. 2008; 49 (10): 1854-9